Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA repair process refers to a collection of multiple pathways. It is not a single molecule but an array of tightly regulated molecular systems safeguarding genome stability through diverse enzymatic activities tailored for different types of genetic lesions. These pathways include Direct Reversal, Base Excision Repair (BER), Nucleotide Excision Repair (NER), Mismatch Repair (MMR), Homologous Recombination (HR), and Non-Homologous End Joining (NHEJ).
Varies depending on the specific repair pathway and drug; e.g., PARP inhibitors block PARP-mediated DNA repair, leading to synthetic lethality in cells with HR deficiency.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Repair Process.